Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for CompuMed Inc. (CMPD : OTC)
 
 • Company Description   
COMPUMED, INC. is a medical systems company engaged primarily in the application of computer technology to medicine. The main aspects of Co.'s business are (i) the licensing of its proprietary technology in the OsteoGramR, a bone density test that was developed by the Company as a means of aiding physicians in diagnosing and monitoring osteoporosis, (ii) the computer interpretation of electrocardiograms, (iii) TeleCor Services Division, which is engaged in transtelephonic cardiac event monitoring.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $3.52 Daily Weekly Monthly
20 Day Moving Average: 2,325 shares
Shares Outstanding: 1.33 (millions)
Market Capitalization: $4.67 (millions)
Beta: 0.10
52 Week High: $4.70
52 Week Low: $2.00
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -8.94% -12.89%
12 Week 17.33% -4.27%
Year To Date -7.61% -12.43%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
5777 West Century Blvd. Suite 360
-
Los Angeles,CA 90045
USA
ph: 310-258-5000
fax: 310-645-5880
investorrelations@compumedinc.com http://www.compumedinc.com
 
 • General Corporate Information   
Officers
Lee Keddie - Chief Executive Officer and President
David W. Pointer - Chairman
Laura Carroll - Chief Financial Officer and Corporate Secretary
Loren Den Herder - Director
Charles Gillman - Director

Peer Information
CompuMed Inc. (BJCT)
CompuMed Inc. (CADMQ)
CompuMed Inc. (APNO)
CompuMed Inc. (UPDC)
CompuMed Inc. (IMTIQ)
CompuMed Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 204914501
SIC: 7374
Fiscal Year
Fiscal Year End: September
Last Reported Quarter: 12/01/24
Next Expected EPS Date: 08/13/25
Share - Related Items
Shares Outstanding: 1.33
Most Recent Split Date: 5.00 (0.04:1)
Beta: 0.10
Market Capitalization: $4.67 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/13/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: 20.71
PEG Ratio: -
Price Ratios
Price/Book: 1.38
Price/Cash Flow: 5.11
Price / Sales: 0.69
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 0.00%
Sales Growth
vs. Year Ago Period: 20.37%
vs. Previous Quarter: 12.06%
ROE
06/30/25 - -
03/31/25 - 6.43
12/31/24 - 6.85
ROA
06/30/25 - -
03/31/25 - 4.53
12/31/24 - 4.96
Current Ratio
06/30/25 - -
03/31/25 - 2.72
12/31/24 - 3.15
Quick Ratio
06/30/25 - -
03/31/25 - 2.55
12/31/24 - 2.85
Operating Margin
06/30/25 - -
03/31/25 - 3.13
12/31/24 - 3.44
Net Margin
06/30/25 - -
03/31/25 - 3.13
12/31/24 - 3.44
Pre-Tax Margin
06/30/25 - -
03/31/25 - 0.93
12/31/24 - 0.86
Book Value
06/30/25 - -
03/31/25 - 2.55
12/31/24 - 2.51
Inventory Turnover
06/30/25 - -
03/31/25 - 4.02
12/31/24 - 2.76
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.18
12/31/24 - 0.09
Debt-to-Capital
06/30/25 - -
03/31/25 - 15.15
12/31/24 - 8.12
 

Powered by Zacks Investment Research ©